FGFR2 and neoplasm: In vivo tumor growth after the inoculation of mixtures of Mock and FGFR2-Fc–expressing tumor cells was similar to that of Mock cells alone in the Renca model, but was slower than that of Mock cells alone in the B16F10 model.